Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

OTC Obesity - Greece

151 views

Published on

In line with EU regulations, products in OTC obesity were not available in Greece in 2008. However, in October 2008, the European Medicines Agency (EMEA) authorised the switching of active ingredient Orlistat (60mg). In this context, GlaxoSmithKline was granted licence for the launch of its Alli brand in Greece, introduced at the end of November 2009. Available in a bottle of 84 hard capsules of 60mg, this 'diet pill' is characterised as GlaxoSmithKline's 'de-tuned' version of the popular...Euromonitor International's OTC Obesity Products in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change. Product coverage: Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.Why buy this report' * Get a detailed picture of the Consumer Health industry; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Published in: Business, Travel
  • Hi! Get Your Professional Job-Winning Resume Here! 👉 http://bit.ly/rexumtop
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

OTC Obesity - Greece

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!OTC Obesity - GreecePublished on March 2010 Report SummaryIn line with EU regulations, products in OTC obesity were not available in Greece in 2008. However, in October 2008, the EuropeanMedicines Agency (EMEA) authorised the switching of active ingredient Orlistat (60mg). In this context, GlaxoSmithKline was grantedlicence for the launch of its Alli brand in Greece, introduced at the end of November 2009. Available in a bottle of 84 hard capsules of60mg, this diet pill is characterised as GlaxoSmithKlines de-tuned version of the popular...Euromonitor Internationals OTC Obesity Products in Greece report offers a comprehensive guide to the size and shape of the marketat a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to2014 illustrate how the market is set to change.Product coverage:Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.Why buy this report* Get a detailed picture of the Consumer Health industry;* Pinpoint growth sectors and identify factors driving change;* Understand the competitive environment, the markets major players and leading brands;* Use five-year forecasts to assess how the market is predicted to develop.Euromonitor International has over 30 years experience of publishing market research reports, business reference books and onlineinformation systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a networkof over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to helpdrive informed strategic planning. Table of ContentOTC Obesity in GreeceEuromonitor InternationalMarch 2010List of Contents and TablesExecutive SummaryRecession Has Marginal Effect on Consumer HealthcareSmokers and Obese Consumers Drive SalesScepticism and Loyalty Continues To Hinder New EntrantsHealthfood Stores Continue To ExpandRecession Expected To Bypass Consumer HealthcareKey Trends and DevelopmentsOTC Obesity - Greece Page 1/5
  2. 2. Find Industry reports, Company profilesReportLinker and Market StatisticsMerging Health and Beauty Trends Impact HealthcareEffects of the Recession and Growing Price AwarenessContemporary Lifestyles Offer Prosperous Ground for GrowthReluctance and Scepticism About Product Effectiveness Still Hinders PenetrationManufacturers Acknowledge the Significance of CommunicationMarket IndicatorsTable 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009Table 2 Life Expectancy at Birth 2004-2009Market DataTable 3 Sales of Consumer Health by Sector: Value 2004-2009Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009Table 5 Consumer Health Company Shares by Value 2005-2009Table 6 Consumer Health Brand Shares by Value 2006-2009Table 7 Penetration of Private Label by Sector 2004-2009Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014AppendixOTC Registration and ClassificationAdvertisingPackagingLabellingDistributionPricingVitamins and Dietary Supplements Registration and ClassificationEU LegislationSelf-medication and Preventative MedicineGenericsSwitchesDefinitionsSummary 1 Research SourcesAlapis Pharma SAStrategic DirectionKey FactsSummary 2 Alapis Pharma SA: Key FactsSummary 3 Alapis Pharma SA: Operational IndicatorsCompany BackgroundProductionCompetitive PositioningSummary 4 Alapis Pharma SA: Competitive Position 2009Elpen SAStrategic DirectionKey FactsSummary 5 Elpen SA: Key FactsSummary 6 Elpen SA: Operational IndicatorsCompany BackgroundProductionCompetitive PositioningSummary 7 Elpen SA: Competitive Position 2009OTC Obesity - Greece Page 2/5
  3. 3. Find Industry reports, Company profilesReportLinker and Market StatisticsIso Plus SAStrategic DirectionKey FactsSummary 8 Iso Plus SA: Key FactsSummary 9 Iso Plus SA: Operational IndicatorsCompany BackgroundProductionCompetitive PositioningSummary 10 Iso Plus SA: Competitive Position 2009Korres Natural Products SAStrategic DirectionKey FactsSummary 11 Korres Natural Products SA: Key FactsSummary 12 Korres Natural Products SA: Operational IndicatorsCompany BackgroundProductionCompetitive PositioningPower Health Hellas SAStrategic DirectionKey FactsSummary 14 Power Health Hellas SA: Key FactsSummary 15 Power Health Hellas SA: Operational IndicatorsCompany BackgroundProductionCompetitive PositioningSummary 16 Power Health Hellas SA: Competitive Position 2009TrendsCategory DataTable 12 Sales of OTC Obesity: Value 2009Table 13 OTC Obesity Company Shares by Value 2005-2009Table 14 OTC Obesity Brand Shares by Value 2006-2009Table 15 Forecast Sales of OTC Obesity: Value 2009-2014Table 16 Forecast Sales of OTC Obesity: % Value Growth 2009-2014OTC Obesity - Greece Page 3/5
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. OTC Obesity - Greece Product Formats Please select the product formats and the quantity you require. Digital Copy--USD 957.60 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________OTC Obesity - Greece Page 4/5
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93OTC Obesity - Greece Page 5/5

×